会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Multilayer wound covering materials comprising a supporting layer and a
moisture permeation controlling layer and method for their manufacture
    • 包括支撑层和水分渗透控制层的多层缠绕覆盖材料及其制造方法
    • US5395305A
    • 1995-03-07
    • US745889
    • 1991-08-16
    • Mikio KoideJun KonishiKazuhito IkegamiKen-ichi Osaki
    • Mikio KoideJun KonishiKazuhito IkegamiKen-ichi Osaki
    • A61L15/52A61L15/60A61F13/00
    • A61L15/52A61L15/60
    • Wound-covering materials comprising two layers, a first support layer which is to be in contact with a wound and a second moisture permeation-controlling layer which may optionally contain an antimicrobial agent are taught. The support layer is formed from a biocompatible highly aqueous gel-forming substance, e.g., carboxymethylcelluloses, alginates, hyaluronates, poly(meth)acrylates, chitosan derivatives and chitin derivatives, and at least a portion of the support layer which is to be in contact with a wound is coated with a water-repellant substance, e.g., silicones, polyurethanes, styrene-butadiene-styrene block copolymers and polytetrafluoroethylenes. The moisture permeation controlling layer may, e.g., be formed from steam permeable resin films made of silicone or polyurethane elastomers. The resultant wound-covering materials inhibit infection and pain, maintain adequate water retention, and do not produce bioincompatibility responses when applied to the site of wounds.
    • 教导包括两层的缠绕覆盖材料,与伤口接触的第一支撑层和可选地含有抗微生物剂的第二湿度渗透控制层。 支撑层由生物相容性高含水凝胶形成物质形成,例如羧甲基纤维素,藻酸盐,透明质酸盐,聚(甲基)丙烯酸酯,壳聚糖衍生物和几丁质衍生物,以及至少一部分待接触的载体层 用伤口涂覆防水物质,例如硅氧烷,聚氨酯,苯乙烯 - 丁二烯 - 苯乙烯嵌段共聚物和聚四氟乙烯。 水分渗透控制层可以例如由由硅氧烷或聚氨酯弹性体制成的透湿树脂膜形成。 所得的伤口覆盖材料抑制感染和疼痛,保持足够的保水性,并且当施用于伤口部位时不产生生物相容性反应。
    • 3. 发明授权
    • Compositions of polyvinyl chloride and tetracarboxylic tetraesters and
medical articles thereof
    • 聚氯乙烯和四羧酸四酯的组合物及其医药制品
    • US4560720A
    • 1985-12-24
    • US542355
    • 1983-10-17
    • Juuro AoyagiToshiji IchikawaMikio KoideTakeshi Shimomura
    • Juuro AoyagiToshiji IchikawaMikio KoideTakeshi Shimomura
    • A61L29/00A61J1/00A61J1/05C08K5/12C08K5/375C08K5/41C08K5/10
    • A61J1/10C08K5/12C08K5/375C08K5/41
    • Medical articles made of a resin composition comprising a polyvinyl chloride and a tetracarboxylic tetraester are provided. As examples of the tetracarboxylic tetraester are mentioned tetra(2-ethylhexyl) 3,3',4,4'-biphenylethertetracarboxylate, tetra(2-ethylhexyl) 3,3',4,4'-biphenylmethanetetracarboxylate, tetra(n-dodecyl) 2,3,3',4'-biphenyl-1,1-ethanetetracarboxylate, tetra(2-ethylhexyl) 3,3',4,4'-biphenyl-2,2-propanetetracarboxylate and the like. The tetracarboxylic tetraester is incorporated in an amount from 20 to 120, preferably from 30 to 100 parts by weight per 100 parts by weight of the polyvinyl chloride. As dissolution and migration to the surface of the article of the plasticizer tetracarboxylic tetraester are low in the medical articles, said medical articles produce no adverse effects upon body fluids such as blood when contacted. Examples of preferred medical articles are blood preservation vessels, catheters and blood transfusion sets.
    • 提供由包含聚氯乙烯和四羧酸四酯的树脂组合物制成的医疗制品。 提到四羧酸四酯的四(2-乙基己基)3,3',4,4'-联苯基醚四羧酸四(2-乙基己基)3,3',4,4'-联苯甲烷四羧酸四(正十二烷基)酯, 2,3,3',4'-联苯-1,1-乙烷四羧酸酯,3,3',4,4'-联苯基-2,2-丙烷四羧酸四(2-乙基己基)酯,4,4'-联苯基-2,2-丙烷四羧酸酯等。 四羧酸四酯的含量为每100重量份聚氯乙烯20至120重量份,优选30至100重量份。 由于溶解和向塑化剂四羧酸四酯的制品的表面迁移到医疗制品中,所以医疗制品在接触时不会对体液如血液产生不利影响。 优选医疗制品的实例是保血管,导管和输血组。